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Abstract
Objective: To determine the safety and efficacy of altering the ratio of carbohydrate and protein
in low-energy diets in conjunction with a popular exercise program in obese women.
Design: Matched, prospective clinical intervention study to assess efficacy of varying ratios of
carbohydrate and protein intake in conjunction with a regular exercise program.
Participants: One-hundred sixty one sedentary, obese, pre-menopausal women (38.5 ± 8.5 yrs,
164.2 ± 6.7 cm, 94.2 ± 18.8 kg, 34.9 ± 6.4 kg·m-2, 43.8 ± 4.2%) participated in this study. Participants
were weight stable and not participating in additional weight loss programs.
Methods: Participants were assigned to either a no exercise + no diet control (CON), a no diet
+ exercise group (ND), or one of four diet + exercise groups (presented as kcals; % carbohydrate:
protein: fat): 1) a high energy, high carbohydrate, low protein diet (HED) [2,600; 55:15:30%], 2) a
very low carbohydrate, high protein diet (VLCHP) [1,200 kcals; 63:7:30%], 3) a low carbohydrate,
moderate protein diet (LCMP) [1,200 kcals; 50:20:30%] and 4) a high carbohydrate, low protein
diet (HCLP) [1,200 kcals; 55:15:30%]. Participants in exercise groups (all but CON) performed a
pneumatic resistance-based, circuit training program under supervision three times per week.
Measurements: Anthropometric, body composition, resting energy expenditure (REE), fasting
blood samples and muscular fitness assessments were examined at baseline and weeks 2, 10 and 14.
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Results: All groups except CON experienced significant reductions (P < 0.05 – 0.001) in waist
circumference over 14 weeks. VLCHP, LCHP and LPHC participants experienced similar but
significant (P < 0.05 – 0.001) reductions in body mass when compared to other groups. Delta
responses indicated that fat loss after 14 weeks was significantly greatest in VLCHP (95% CI: -5.2,
-3.2 kg), LCMP (-4.0, -1.9 kg) and HCLP (-3.8, -2.1 kg) when compared to other groups. Subsequent
reductions in % body fat were significantly greater in VLCHP, LCMP and HCLP participants. Initial
dieting decreased (P < 0.05) relative REE similarly in all groups. All exercise groups significantly (P
< 0.05) improved in muscular fitness, but these improvements were not different among groups.
Favorable but non-significant mean changes occurred in lipid panels, glucose and HOMA-IR. Leptin
levels decreased (P < 0.05) in all groups, except for CON, after two weeks of dieting and remained
lower throughout the 14 week program. Exercise participation resulted in significant
improvements in quality of life and body image.
Conclusion: Exercise alone (ND) appears to have minimal impact on measured outcomes with
positive outcomes apparent when exercise is combined with a hypoenergetic diet. Greater
improvements in waist circumference and body composition occurred when carbohydrate is
replaced in the diet with protein. Weight loss in all diet groups (VLCHP, LCMP and HCLP) was
primarily fat and stimulated improvements in markers of cardiovascular disease risk, body
composition, energy expenditure and psychosocial parameters.
Introduction
The prevalence of obesity in the United States and
throughout the world continues to increase. An estimated
1.2 billion people in the world are overweight with 300
million of them being obese [1,2]. Research over the last
several decades indicates that regular activity and appro-
priate energy intake can play critical roles in preventing
and managing the negative health consequences of diabe-
tes, obesity and other cardiovascular diseases [3-7]. Ini-
tially, weight loss programs focused on restricting energy
intake, but sharp reductions in energy intake have been
shown to result in fat-free mass reductions and negatively
impact metabolic rate [8]. Replacing dietary carbohydrate
with protein without changing fat intake continues to be
researched as a potential strategy to improve health and
promote weight loss. While replacing dietary protein with
fat in isocaloric amounts doesn't appear to improve the
loss of body mass [9-11], studies in the last several years
have shown that following diets which replace carbohy-
drate with protein may stimulate greater weight loss
[12,13] and improve body composition changes [12,14-
16]. Interestingly, findings have also reported that replac-
ing dietary carbohydrate with protein may also improve
serum-based markers of diabetes and cardiovascular dis-
ease (e.g. fasting insulin, glycemic responses, triglycerides
and total cholesterol) [12,14-16]. While many of these
studies examined a dietary intervention, several did not
include any form of exercise component [14-16]. For
those studies that did investigate a combination of dietary
intake with and without exercise, some have lacked addi-
tional control measures to fully elucidate the impact of
these dietary approaches when combined with a pro-
longed exercise intervention [12,13]. Furthermore, the
mode of exercise is an important consideration, and the
incorporation of some aspect of resistance-based exercise
during a weight loss program may help to maintain fat
free mass, sustain resting energy expenditure levels and
promote higher levels of function [8]. Currently, the
number of investigations that have combined a resistance-
based exercise program with a dietary intervention that
focuses on replacing carbohydrate with protein is limited
[8], making it difficult to adequately determine which
form of exercise and dietary intervention has the greatest
potential to help people achieve their weight loss and
other health-related goals.
Curves International is currently the largest fitness fran-
chise in the world with over 4 million members in 10,000
clubs in over 69 countries [17]. The typical Curves mem-
ber is a 30 – 60 year old sedentary female who ranges from
being slightly overweight to obese according to BMI
standards [18]. The Curves program attracts a large seg-
ment of women to participate in their program who have
many times previously avoided exercising at coed fitness
facilities and unsuccessful with prior weight loss efforts
[19]. Moreover, rather than incorporating traditional
forms of aerobic exercise as the primary mode of physical
activity, participants in the Curves program perform bi-
directional, pneumatic resistance-training exercises (in a
circuit format) interspersed with low-impact callisthenic
exercises for 30-minutes, three times per week [19]. In
conjunction with the exercise program, several dietary reg-
imens are utilized throughout the program. A high calo-
rie, high carbohydrate, low protein low fat diet (2,600
kcals: 55:15:30% (carbohydrate: protein: fat) is recom-
mended for women who have low resting energy expend-
iture, defined as <10% below predicted RMR [20], and a
low daily energy intakes. Otherwise, a low calorie, low car-Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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bohydrate, high protein, low fat diet (1,000 – 1,200 kcals:
20:50:30%) or a low calorie, high carbohydrate, low pro-
tein, low fat diet (1,000 – 1,200 kcals: 55:15:30%) is rec-
ommended depending on carbohydrate tolerance for an
initial diet period of 2 – 4 weeks before increasing caloric
intake to 1,600 kcals while maintaining a similar (but not
identical) macronutrient distribution until weight loss
goals are achieved. Once achieved, weight maintenance is
promoted by adhering to a 2,200 – 2,600 kcals·d-1 diet
based on American Dietetic Association guidelines (% car-
bohydrate:protein:fat = 55:15:30) with intermittent peri-
ods of reduced caloric intake (e.g. 1,200 kcals·d-1) for
period of 2 to 3 days. This program was designed as a
means to promote and sustain weight loss in women
while preserving fat free mass and resting energy expendi-
ture [19].
While previous research provides general conceptual sup-
port for this program, the safety and efficacy of the Curves
program has yet to be investigated. Therefore, the objec-
tives of this study were two-fold: 1) to examine the effi-
cacy of replacing dietary carbohydrate with protein while
completing a weekly resistance-based circuit exercise pro-
gram and 2) to determine the safety and efficacy of follow-
ing the Curves fitness and weight loss program [19] over a
prolonged period. It was hypothesized that all groups par-
ticipating in the exercise program, irrespective of dietary
assignment, would experience significant improvements
in anthropometric measures, body composition, and
improve their fitness and risk for cardiovascular disease.
Further hypotheses were made that those participants fol-
lowing diets that replaced dietary carbohydrate with pro-
tein would experience greater improvements in
anthropometrics and body composition in addition to
greater improvements in cardiovascular disease markers.
Methods
Experimental Approach
Two primary objectives were studied in this investigation,
first to examine the impact of replacing dietary carbohy-
drate with dietary protein to varying degrees and second
to assess the effectiveness of following the exercise and
diet recommendations of the Curves program that were
published at the time this study was initiated [19]. Partic-
ipants were placed into one of six groups: no diet + no
exercise control (CON), no diet + exercise (ND), high car-
bohydrate, high energy diet (HED) + exercise (2,600;
55:15:30%); very low carbohydrate, high protein
(VLCHP) + exercise (1,200; 63:7:30%), low carbohydrate,
moderate protein (LCMP) + exercise (1,200: 50:20:30%),
high carbohydrate, low protein (HCLP) + exercise group
(1,200: 55:15:30%). All participants were tested over the
course of a 14 week period for changes in anthropomet-
rics, body composition, cardiovascular and muscular fit-
ness, serum and whole clinical and hormonal changes
and psychosocial parameters after 0, 2, 10, and 14 weeks
of following their assigned diet and exercise program. Pri-
mary outcomes in this study were identified as waist cir-
cumference while all secondary outcomes were body mass
and DXA body composition parameters. Finally, tertiary
outcomes were associated with changes in resting energy
expenditure, cardiovascular and muscular fitness and all
serum and whole blood safety and hormonal markers.
Testing after 2 weeks was completed to assess the acute
changes in energy expenditure and hormonal status after
the most energy-restrictive phase of the diets (1,200
kcals·d-1) while testing at 10 and 14 weeks provide for fol-
low-up assessments after less-restrictive phases of the diet-
ing program. Participation in the exercise program was
hypothesized to promote greater improvements in all pri-
mary and secondary outcomes measures when compared
to the non-exercise controls (CON). A standard consort
diagram is available which outlines the number of partic-
ipants who were screened (n = 290), assigned to a group
(n = 242), including how many to each intervention
group and those that completed the entire 14 week proto-
col (n = 161) (see Figure 1).
Participants
One-hundred sixty one sedentary, obese, female partici-
pants (38.5 ± 8.5 yrs, 164.2 ± 6.7 cm, 94.2 ± 18.8 kg, 34.9
± 6.4 kg·m-2, 43.8 ± 4.2%) participated in this study
(Table 1). Participants were not allowed to participate in
this study if at baseline they reported: 1.) being currently
diagnosed with any metabolic or cardiovascular disorder
including known electrolyte abnormalities; heart disease,
arrhythmias, diabetes, thyroid disease, hypogonadism; or
a history of hypertension, hepatorenal, musculoskeletal,
autoimmune, or neurologic disease; 2.) any current pre-
scriptions for thyroid, hyperlipidemic, hypoglycemic,
anti-hypertensive, or androgenic medications; 3.) taking
any ergogenic levels of nutritional supplements that may
affect muscle mass (e.g. creatine, β-hydroxy-β-methylbu-
tyrate [HMB]), dehydroepiandrosterone [DHEA], or
weight loss (e.g. ephedra, thermogenics, etc) within one
year prior to the starting the study; 4.) any condition
which classified them as high risk for cardiovascular dis-
ease according to American College of Sports Medicine
criteria [21]; 5) participating in any other form of a diet or
exercise program during the 12 months prior to starting
the study. Participants meeting eligibility criteria were
informed of the requirements of the study and signed
informed consent statements in compliance with the
Human Subjects Guidelines of Baylor University and the
American College of Sports Medicine.
Testing Sessions
Recruitment occurred by flyers posted in local newspa-
pers, campus flyers and television announcements. Inter-
ested participants first contacted the laboratory for pre-Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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screening before completing a familiarization session
where they were additionally screened and provided
detailed information about the exercise program, diet and
testing protocols. All participants completed informed
consent documents during this familiarizations session.
Prior to all testing sessions including baseline, partici-
pants completed a 4 d dietary record, observed an 8 h fast
and refrained from vigorous physical activity for 24 h
prior to each testing session. All testing sessions were
scheduled at similar times in the morning to control for
diurnal variations. All baseline, 10 week and 14 week test-
ing sessions, respectively, were identical in nature and
consisted of blood collection (blood lipids, metabolic
panels), anthropometric assessments (body mass, body
mass index, waist circumference), resting energy expendi-
ture, muscular fitness and cardiorespiratory assessments,
body composition analysis (DXA) and psychosocial
assessments (e.g. short-form-36 (SF-36) quality of life,
social physique anxiety scale (SPA), Rosenberg self-
esteem scale (RSE), Cash Body Image questionnaire). An
additional testing session occurred after 2 weeks of dieting
and consisted of all baseline measures with the exception
of cardiorespiratory and muscular fitness assessments.
Upon completion of baseline testing, all participants,
with the exception of the no exercise control group
(CON), began a thrice weekly 30 min pneumatic circuit-
style resistance-based circuit exercise program inter-
spersed with callisthenic activities. During each workout,
fitness supervisors provided exercise instruction and
assisted with self-monitoring of heart rate to maintain an
exercise heart rate between 60–80% target heart rate using
age-predicted maximal heart rate (220 – age) and the Kar-
vonen method.
Diet Assignments
Upon completion of baseline testing, participants were
matched according to body mass and age into either a no
diet + no exercise control (CON), a no diet + exercise
group (ND), or one of four dietary regimens. The diets fol-
lowed the Curves diet recommendations at the time this
study was conducted [19] and consisted of replacing die-
tary carbohydrate with dietary protein while keeping die-
tary fat intake standardized at 30% of total daily caloric
intake [14]. Participant's whose measured REE was less
than 90% of predicted REE (no activity factor was incor-
porated) using the Harris-Benedict prediction equation
[22] were categorized as hypo-metabolic [23]. They were
assigned to follow a 2,600 kcals·d1 at a macronutrient
ratio of 55:15:30% (carbohydrate:protein:fat), high-
energy, high carbohydrate diet (HED) for 14 weeks to
assess anthropometric and weight loss changes. A brief
questionnaire was administered to all participants at
familiarization to provide a qualitative indication of car-
bohydrate/glycemic tolerance, which is used by the
Curves program to assist with dietary assignment and thus
was adopted as part of this investigation [19]. Recent stud-
ies by our group have illustrated that in a large group of
overweight and obese women this questionnaire effec-
tively associates responses with indicators of metabolic
syndrome [24,25]. Those participants responding in a
positive fashion (e.g. provided answers indicative of car-
bohydrate intolerance) were assigned to either the VLCHP
or LCMP groups. Participants responding negatively were
assigned to the HCLP diet [19]. In each of these diets, par-
ticipants ingested 1,200 kcals·d-1 for 2-weeks (phase 1).
Over the next 8-weeks, energy intake was increased to
1,600 kcals·d-1 (phase 2) providing for a weight loss
period of 10 weeks consisting of caloric intakes ranging
from 1,200 – 1,600 kcals·d-1. The remaining 4 weeks
(phase 3) utilized a weight maintenance approach in
which participants followed a 2,600 kcals·d-1 using the
recommend macronutrient breakdown (55:15:30%; car-
bohydrate: protein: fat) by the American Dietetic Associa-
tion with intermittent 2 – 3 day periods of phase 1 dieting.
Similar weight maintenance models have been previously
investigated [14] for their effectiveness and this approach
is utilized as a weight maintenance approach during this
program. To facilitate adherence and comprehension of
each dietary assignment, a team of reregistered dieticians
performed an additional diet familiarization session with
each participant and developed customized menu book-
lets, providing sample diets and food substitutions for
each diet phase. The booklets were used as checklists upon
which all study participants were required to return after
completing the study. Food logs were maintained for 4
days prior to each testing session. Registered dietitians
Standard consort diagram illustrating people who provided  interest in participating, those that were screened, how  group assignments were made, who completed program and  reasons for termination of participation Figure 1
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Table 1: Baseline anthropometric, dietary analysis, body composition and biochemical parameters for the high energy, high 
carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise 
(VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein 
diet + exercise (HCLP: 1,200; 55:15:30) and no diet + no exercise control (CON).
Demographics Grand Mean HED ND VLCHP LCMP HCLP CON P-
value
Age (years) 38 ± 9 35 ± 10 37 ± 10 39 ± 7 38 ± 9 41 ± 8 32 ± 10 0.10
Height (cm) 164 ± 7 164 ± 6 163 ± 8 165 ± 6 165 ± 7 163 ± 7 163 ± 6 0.65
Weight (kg) 94 ± 19 93 ± 13 81 ± 13d 108 ± 19 92 ± 18d 87 ± 13d 89 ± 18 <0.001
Body mass index 35 ± 6 34 ± 4 31 ± 4d 39 ± 7 34 ± 6d 33 ± 4d 34 ± 6 <0.001
(kg·m-2)
Waist (cm) 101 ± 13 104 ± 7 93 ± 12d 108 ± 14 101 ± 13 96 ± 11d 95 ± 13 <0.001
DXA fat-free mass (kg) 49 ± 8 49 ± 7 43 ± 7d 54 ± 7 48 ± 8d 45 ± 6d 48 ± 6 <0.001
DXA fat mass (kg) 39 ± 11 37 ± 7 32 ± 7d 46 ± 12 37 ± 10d 35 ± 8d 38 ± 9 <0.001
REE (kcals·d-1) 1730 ± 300 1331 ± 193 1595 ± 228d, f 1955 ± 278f 1705 ± 249d, f 1645 ± 222d, f 1753 ± 274f <0.001
Systolic blood pressure 
(mm Hg)
125 ± 13 127 ± 20 119 ± 10 129 ± 15 124 ± 9 126 ± 10 121 ± 14 0.10
Diastolic blood pressure 
(mm Hg)
83 ± 8 86 ± 14 79 ± 7 84 ± 8 83 ± 8 84 ± 7 79 ± 7 0.13
VO2 (ml/kg/min) 21 ± 5 22 ± 3 24 ± 5 19 ± 6 22 ± 5 22 ± 4 23 ± 5 <0.001
Biochemical parameters Grand Mean HED ND VLCHP LCMP HCLP CON P-
value
Total cholesterol 5.0 ± 0.9 4.9 ± 0.8 5.1 ± 0.9 4.9 ± 0.7 5.0 ± 0.9 5.1 ± 1.1 5.3 ± 1.1 0.87
(mmol·L-1)
HDL cholesterol 1.4 ± 0.3 1.3 ± 0.2 1.4 ± 0.3 1.3 ± 0.3 1.4 ± 0.3 1.4 ± 0.2 1.3 ± 0.3 0.36
(mmol·L-1)
LDL cholesterol 3.0 ± 0.8 3.1 ± 0.7 3.1 ± 0.8 3.0 ± 0.6 2.8 ± 0.8 3.0 ± 1.0 3.3 ± 0.9 0.62
(mmol·L-1)
Triglycerides 1.5 ± 0.9 1.0 ± 0.4 1.3 ± 0.5 1.6 ± 1.1 1.5 ± 0.9 1.5 ± 0.7 1.6 ± 0.8 0.50
(mmol·L-1)
Glucose 5.3 ± 0.7 5.1 ± 0.5 5.0 ± 0.3 5.3 ± 0.7 5.3 ± 0.9 5.3 ± 0.5 5.2 ± 0.7 0.57
(mmol·L-1)
Insulin 4.9 ± 4.0 3.3 ± 1.6 4.3 ± 2.3 6.0 ± 3.9 5.9 ± 6.0 3.8 ± 2.4 3.7 ± 2.0 <0.05
(pmol·L-1)
HOMA-IR 1.15 ± 1.0 0.75 ± 0.4 0.95 ± 0.5 1.43 ± 1.0 1.40 ± 1.4 0.89 ± 0.6 0.89 ± 0.6 <0.05
Leptin 103 ± 48 98 ± 39 94 ± 35 107 ± 37 113 ± 67 99 ± 48 84 ± 39 0.56
(pgm·L-1)
Dietary Intake Grand Mean HED ND VLCHP LCMP HCLP CON P-
value
Caloric intake (kcal/kg/day) 22.4 ± 6.9 23.7 ± 4.2 21.2 ± 6.6 20.5 ± 7.5 23.3 ± 7.5 23.6 ± 6.0 --- 0.29
Carbohydrate (g/kg/day) 2.8 ± 1.1 3.0 ± 0.8 2.7 ± 0.8 2.4 ± 1.4 2.8 ± 1.1 3.1 ± 1.0 --- 0.19
Protein (g/kg/day) 0.88 ± 0.3 1.0 ± 0.2 0.8 ± 0.2 0.9 ± 0.4 0.9 ± 0.5 0.8 ± 0.2 --- 0.76
Fat (g/kg/day) 0.89 ± 0.3 0.9 ± 0.2 0.8 ± 0.4 0.9 ± 0.4 0.9 ± 0.4 0.9 ± 0.3 --- 0.90
All data is presented as means ± SD at baseline. Significance level was set at 0.05.
dDifferent than VLCHP, P < 0.001 – 0.05; fDifferent than HED, P < 0.001. NOTE: No other differences at baseline existed (P > 0.05).Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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reviewed the dietary records with the participant to pro-
mote compliance to the diet programs.
Procedures
Dietary Inventories
Prior to each testing session, participants recorded all food
and fluid intake over a 4-d period (including one weekend
day), which was reflective of their normal dietary intake.
Dietary inventories were then reviewed by a registered die-
tician and analyzed for average caloric and macronutrient
intake using ESHA Food Processor (Version 8.6) Nutri-
tional Analysis software (Salem, OR).
Anthropometrics
Each testing session, height and body mass were deter-
mined according to standard procedures using a Heal-
thometer (Bridgeview, IL) self-calibrating digital scale
with an accuracy of ± 0.02 kg. Waist circumference was
measured using a Golnick tensiometer using standard
ACSM criteria [21]. Resting heart rate was measured via
palpation of the radial artery and resting blood pressure
was determined using a mercury sphygomometer (Ameri-
can Diagnostic Corporation, model # AD-720, Haup-
puage, NY) according to previously accepted procedures
[21].
Body Composition and Energy Expenditure Assessments
Resting energy expenditure (REE) assessments were made
using a Parvo Medics TrueMax 2400 Metabolic Measure-
ment System (Sandy, UT). This test was a non-exertional
test performed in a fasted state with the participants lying
supine on an exam table. A clear, hard plastic hood and
soft, clear plastic drape was placed over the participants'
neck and head in order to determine resting oxygen
uptake and energy expenditure. All participants remained
motionless without falling asleep for approximately 20
minutes. Data were recorded after the first ten minutes of
testing during a five minute period of time in which crite-
rion variables (e.g. VO2 [Lmin-1]) changed less than 5%
[26]. Using a sub-sample of 14 participants from this
investigation, test-retest correlations (r) of collected VO2
in L·min1 ranged from 0.315 – 0.901 ( : 0.638) and
coefficient of variation ranged from 8.2% – 12.0% ( :
9.9%) with a mean intra-class coefficient of 0.942, p <
0.001. Participants then had their bone density and body
composition assessed with a whole-body scan using a
Hologic QDR-4500W DXA using software version 9.8
(Waltham, MA). Mean coefficients of variation in bone
mineral content and bone mineral density measurements
on the spine phantom ranged between 0.41 – 0.55%.
Test-retest reliability studies performed on male athletes
with this DXA machine have previously yielded mean
coefficients of variation for total bone mineral content
and total fat free/soft tissue mass of 0.31 – 0.45% with a
mean intra-class correlation of 0.985 [27].
Cardiopulmonary Exercise Tests
At baseline and after 10 and 14 weeks, participants com-
pleted a peak cardiopulmonary exercise test according to
the Bruce protocol [28]. Using standard electrode place-
ment and a Quinton 710 ECG unit (Bothell, Washington,
USA), 12-lead electrocardiogram tests were also made to
assess heart function according to previously established
criteria [21]. An exercise heart rate of 85% of predicted
maximal heart rate was criteria used to standardized exer-
tion during each test. Standard ACSM test termination cri-
teria were monitored and followed throughout each test
[21]. Resting and exercise expired gases were collected
using a Parvo Medics TrueMax 2400 Metabolic Measure-
ment System (Sandy, Utah, USA). Calibration of gas and
flow sensors was completed every morning prior to testing
and was found to be within 3% of the previous calibration
point.
Maximal Strength and Endurance Assessments
At baseline and after 10 and 14 weeks, participants had
their one-repetition maximum (1 RM) determined using
the bench press and leg press exercises for changes in max-
imal strength. Muscular endurance was assessed by having
participants perform as many repetitions as possible with
80% of their pre-determined 1 RM. Standard lifting tech-
niques and criteria according to National Strength and
Conditioning Association (NSCA) were followed
throughout all testing [29]. Test to test reliability of per-
forming these strength tests in our lab on resistance-
trained participants have yielded low mean coefficients of
variation and high reliability for the bench press (1.9%,
intra-class r = 0.94) and hip sled/leg press (0.7%, intra-
class r = 0.91).
Blood Collection Procedures
Fasted whole blood and serum samples were collected
using standard phlebotomy techniques. Whole blood
samples were analyzed for complete blood counts with
platelet differentials using an Abbott Cell Dyn 3500
(Abbott Laboratories, Abbott Park, Illinois, USA) auto-
mated hematology analyzer. Serum samples were ana-
lyzed for a complete metabolic and thyroid panel
including ketone assessment of beta-hydroxybutyrate
using a calibrated Dade Behring Dimension RXL (Deer-
field, Illinois, USA) automated clinical chemistry ana-
lyzer. Coefficient of variation for the tests using this
analyzer was similar to previously published data for
these tests (range: 1.0 to 9.6%) [30]. Remaining serum
was assayed using standard commercially available (DS
Laboratories, Webster, Texas, USA) enzyme-linked immu-
noabsorbent assays (ELISAs) for leptin and insulin. Serum
X
XNutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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concentrations were assessed in duplicate using a Wallac-
Victor IV (Perkin-Elmer Life Sciences, Boston, Massachu-
setts, USA) micro plate reader at an optical density of 450
nm against a known standard curve using standard ELISA
procedures. Intra- and inter-assay CVs of 5.4 – 6.9 and 3.8
– 7.3% at ~5.0 – 21.1 ng·mL-1 existed for leptin and 1.3 –
2.6 and 5.2 – 6.2% at ~7.84 – 44.23 μIU·ml-1 for insulin,
respectively.
Psychosocial Assessments
Prior to any testing, participants completed the SF-36
Health-Related Quality of life (QOL) inventory [31],
social physique anxiety scale (SPA) [32], Rosenburg self-
esteem scale (RSE) [33], and a Cash body image question-
naire [34].
Exercise Program
With the exception of the CON group, all participants par-
ticipated in a supervised Curves exercise program three
days per week throughout the fourteen week protocol (a
total of 42 workouts). Each circuit-style workout consisted
of 14 exercises (e.g. elbow flexion/extension, knee flex-
ion/extension, shoulder press/lat pull, hip abductor/
adductor, chest press/seated row, horizontal leg press,
squat, abdominal crunch/back extension, pec deck,
oblique, shoulder shrug/dip, hip extension, side bends
and stepping) constructed with pneumatic or hydraulic
resistance that targeted opposing muscle groups in a con-
centric-only fashion. Participants were informed of proper
use of all equipment and were instructed to complete as
many repetitions in a 30 s time period. In a continuous,
interval fashion, participants performed floor-based cal-
listhenic (e.g. running/skipping in place, arm circles, etc.)
exercises for a 30 s time period after each resistance exer-
cise in an effort to maintain a consistent exercise heart rate
that corresponded to 60% to 80% of their maximum heart
rate [21]. All workouts were supervised by trained fitness
instructors who assisted with proper exercise technique
and maintenance of adequate exercise intensity. Partici-
pants were required to complete two complete circuits
which corresponded to exercising for approximately 28
minutes followed by a standardized whole-body stretch-
ing routine. Compliance to the exercise program was set a
priori at a minimum of 70% compliance (30/42 exercise
sessions). Participants were allowed to add an additional
workout on a non-consecutive day to assist with main-
taining appropriate exercise compliance and in rare
instances (n<5), an additional week was added to the
intervention.
Statistical Analysis
All data are presented as means and 95% CI for all varia-
bles for the CON, ND, HED, VLCHP, LCMP and HCLP
groups, respectively. All nutritional intake data was nor-
malized to kilograms of body mass and analyzed using 5
× 4 (without ND group) repeated measures ANOVA.
Eleven participants completed all training and testing, but
did not turn in accurate food records. Consequently, all
statistical analysis of nutritional intake was made on the
remaining 143 participants from the original dataset as
individuals in the CON group (n = 7) completed dietary
analysis at weeks 0 and 14 and were not included in the
statistical analysis. Resting energy expenditure was ana-
lyzed using a 6 × 4 (group × test [0, 2, 10 and 14 weeks])
ANCOVA for baseline body mass. All remaining data were
analyzed using 6 × 3 (group × test [0, 10 and 14 weeks])
repeated measures ANOVA. 14-week change from base-
line (delta) values were calculated and a mean with 95%
confidence interval was instructed to assess changes over
time. When significant group × time interaction effects
were found, factor analysis of the main effects was deter-
mined using pairwise comparisons and one-way ANOVA
when appropriate. Select Pearson correlations were calcu-
lated between the psychosocial and body composition
variables to identify any relationships between these
groups of data. Percent change from baseline was calcu-
lated and reported to evaluate any changes in this data.
Post-hoc power analysis all primary and secondary out-
comes (e.g., waist circumference, body mass, body com-
position via DXA) revealed observed powers values
ranging from 0.821 – 0.998 with partial eta-squared val-
ues ranging from 0.062 – 0.115. All statistical decisions
were made using an alpha level of 0.05. Individual
responses are plotted for waist circumference, body mass,
DEXA fat mass and triglyceride changes while groups
mean are graphed for changes in absolute REE with the




With the exception of the control group (CON) and the
exercise only group (ND), all participants were provided a
diet that provided the desired percentage of carbohydrate,
protein, fat and energy intake. Participants completed 4
day dietary recalls after 0, 2, 10 and 14 weeks of following
their assigned diet and the exercise program. Results show
that participants in the diet groups reduced their energy
intake throughout the program (Time effect: P < 0.001; G
× T; P = 0.10) and altered carbohydrate (G × T; P = 0.001),
protein (G × T; P = 0.01) and fat intake (G × T; P = 0.04)
as intended. Mean values of energy intake, however,
revealed that while participants did alter their diets and
followed the designed patterns, the anticipated caloric
intake for some groups (i.e., particularly the HED group)
did not achieve the intended levels, but this did not influ-
ence the study's ability to investigate the impact of altering
macronutrient ratios in a diet while exercising.Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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Anthropometrics and Body Mass
Waist circumference decreased in the HED, VLCHP and
LCMP after 14 weeks (P < 0.001 for all groups, respec-
tively). After 14 weeks, significant time effects for waist cir-
cumference were found in all groups except CON (Table
2). As expected, when comparing all groups who exercised
against those who did not exercise (CON), a significant
group × time interaction was found for changes in waist
circumference (Figure 2; P < 0.05). After 10 weeks, those
participants who restricted caloric intake and exercised
experienced a significantly greater loss of body mass than
HED, ND and CON (P < 0.01; Figure 3). Participants fol-
lowing the VLCHP diet experienced significantly greater
body mass loss in comparison to the ND (P < 0.005) and
CON (P < 0.005) diets. Similar findings were found for
those individuals following the LCMP diet when com-
pared to the ND (P < 0.005) and CON (P < 0.05) groups.
Loss of body mass for the HCLP approached significance
when compared to the ND (P = 0.077) and CON (P =
0.095) groups, but were subsequently not significant. Fur-
thermore, all participants maintained their body mass
over the last four weeks of the investigation (Table 2; P =
0.63).
Body Composition
Body composition was assessed at 0, 10 and 14 weeks to
determine changes in fat-free and fat mass (Table 2). All
groups that restricted caloric intake and exercised
(VLCHP, LCMP, HCLP) experienced significant but simi-
lar within group reductions over time in DXA fat-free
mass. Similar changes in DXA fat mass (Figure 4) were
found in VLCHP, LCMP and HCLP after both 10 weeks
and 14 weeks which resulted in an overall reduction of
DXA % body fat in the VLCHP, LCMP and HCLP groups
at both 10 weeks and 14 weeks (Table 2). DXA fat reduc-
tions in the VLCHP group were significantly greater after
14 weeks when compared to HED, ND and CON (P <
0.05).
Energy Expenditure
Fasting resting energy expenditure (REE) measurements
were obtained at 0, 2, 10 and 14 weeks (not all data is
shown) to determine changes in resting energy expendi-
ture (Figure 5 and Table 2). To control for the influence of
baseline body mass on REE, analysis of the absolute rest-
ing energy expenditure data was performed using an
ANCOVA and revealed no overall significant group × time
interaction effect (P = 0.45) although significant within-
group increases occurred over time for the HED, ND and
HCLP groups. As expected due to the relationship
between energy intake and expenditure, oneway ANOVA
revealed significantly greater increases from baseline after
2, 10 and 14 weeks (P < 0.001 at all three time points) in
absolute REE for the HED group when compared to all
other groups (Figure 5 and Table 2).
Cardiovascular and Muscular Fitness Changes
At baseline and after 14 weeks of following the diet and
exercise programs, all participants completed maximal
strength and muscular endurance assessments (Table 3).
As expected, exercise training significantly increased rela-
tive peak oxygen uptake in VLCHP (P < 0.001), LCMP (P
< 0.01) and HCLP (P < 0.001) while mean reductions in
resting heart rate (-3.3 ± 16.5%; P = 0.01), systolic blood
pressure (-2.8 ± 12.5%; P = 0.02), mean arterial pressure
(-3.4 ± 10%) and rate pressure product (-5.8 ± 20%)
occurred in these groups (data not shown). No significant
group × time interaction effect was found for bench press
(P = 0.44) or leg press 1 RM (P = 0.38), although those
groups that participated in the exercise program did
achieve significant increases (P < 0.05–0.001) in relative
bench press and leg press 1 RM while CON did not expe-
rience changes in either bench press (P = 0.59) or leg press
1 RM (P = 0.54), respectively. No significant differences
were observed among those groups that exercised for 14
weeks suggesting that all dietary regimens equally
impacted adaptations to exercise training.
Lipid Panels
Lipid panels (e.g. triglycerides, total cholesterol, LDL and
HDL cholesterol) were completed at weeks 0 and 14
(Table 4). No significant interactive effects for total cho-
lesterol (P = 0.90), triglycerides (P = 0.31), HDL choles-
terol (P = 0.78), and LDL cholesterol (P = 0.54) values
were found in any group. Significant reductions in total
cholesterol were found after 14 weeks for found for the
VLCHP and HCLP groups. Furthermore, significant but
similar within group increases in HDL cholesterol were
seen for VLCHP, LCMP and HCLP, but not the HED, ND
or CON groups.
Markers of Fuel Utilization and Energy Regulation
Using serum samples collected at 0 and 14 weeks, serum
concentrations of glucose, insulin, leptin, ketones and a
homeostatic model assessment for insulin resistance
(HOMA-IR) were determined (Table 4) [35]. No signifi-
cant interactive effects were found for glucose (P = 0.68)
and ketones (P = 0.40), while serum glucose levels were
decreased (P < 0.001) in the HCLP group. Serum insulin
(P = 0.08) and HOMA-IR (P = 0.06) values approached
significance for the HCLP group, but were not significant.
Significant within-group reductions in HOMA-IR were
found for the VLCHP, but no other groups (Table 4). A
significant group × time interaction was found for serum
leptin (P < 0.05), with significant reductions occurring
after the initial phase of dietary restriction. In this respect,
leptin levels for all groups except CON (P = 0.07) experi-
enced significant reductions (P < 0.001 to <0.05) after the
first two weeks of dieting, which restricted caloric intake
to the greatest extent.Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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Clinical Safety Markers
Serum and whole blood safety panels were analyzed from
fasting blood after 0 and 14 weeks. While some hemato-
logical variables did report main effects over time with no
significant interaction effects, none of these changes
occurred outside of the clinically accepted normative val-
ues for these variables [36] and thus are not being
reported. No significant main or interaction effects (P >
0.05) were found for found kidney/liver enzymes (e.g.
AST, ALT, GGT, Alk Phos) and markers of protein break-
down (e.g. Uric Acid, BUN, creatinine, BUN:creatinine
ratio, creatine kinase).
Table 2: Anthropometric, body mass, body composition and energy expenditure changes for the high energy, high carbohydrate diet + 
exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), 
low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 
1,200; 55:15:30). 
P-value
Variable Group Mean 14 Week Delta Within Group G × T
Waist (cm) HED -2.8 (-4.3, -1.2)a <0.001 <0.05
ND -5.1 (-8.8, -1.4)a <0.05
VLCHP -6.3 (-8.7, -3.8)a <0.001
LCMP -6.7 (-8.7, -4.8)a <0.001
HCLP -5.7 (-7.5, -3.9)a <0.05
CON 8.2 (+0.3, +16.1) 0.16
Body Mass (kg) HED -1.3 (-3.2, +0.7)c 0.26 <0.001
ND -0.2 (-1.0, +0.6) 0.51
VLCHP -5.6 (- 7.0, -4.3)a, b <0.001
LCMP -6.5 (-10.4, -2.6)a, b <0.01
HCLP -4.0 (-5.0, -3.0)a, b <0.001
CON 1.4 (-0.4, +3.2) 0.28
DXA Fat-Free Mass (kg) HED -0.1 (-0.7, +0.4) 0.36 <0.05
ND 0.1 (-0.6, +0.7) 0.81
VLCHP -1.3 (-1.8, -0.7) <0.001
LCMP -1.1 (-1.6, -0.6) <0.001
HCLP -0.6 (-1.1, -0.1) <0.001
CON 0.5 (-0.8, +1.8) 0.62
DXA Fat Mass (kg) HED -0.9 (-2.7, +0.9)d 0.38 <0.001
ND -0.8 (-1.6, +0.1) 0.09
VLCHP -4.2 (-5.2, -3.2)a, b <0.001
LCMP -2.9 (-4.0, -1.9)a, b <0.001
HCLP -2.9 (-3.8, -2.1)a, b <0.001
CON 0.3 (-1.8, +2.4) 0.85
DXA % Fat (%) HED -0.6 (-1.8, +0.6) 0.42 0.21
ND -0.6 (-1.3+0.2) 0.19
VLCHP -2.0 (-2.7, -1.3) <0.005
LCMP -1.7 (-2.4, -0.9) <0.001
HCLP -2.0 (-2.6, -1.4) <0.001
CON 0.0 (-1.5, +1.5) 0.96
REE (kcals·d-1) HED 413 (+264, +562) <0.001 0.45
ND 83 (-5, +135)e 0.08
VLCHP -37 (-84, +42)e 0.06
LCMP 18 (-58, +94)e 0.52
HCLP 90 (+22, +160)d, e <0.05
CON -30 (-105, +63)e 0.91
Dietary intake is presented as energy (i.e. calories) intake: % carbohydrate: protein: fat. All data is presented as the mean plus the 95% confidence 
intervals for the delta response at week 14. Main effects for time are provided as within-group P-values. Group × time interaction effects are 
provided as GxT P-values. Significance level was set at 0.05.
aDifferent than CON, P < 0.05, bDifferent from ND, P < 0.05, cDifferent from LCMP, P < 0.05, dDifferent than VLCHP, P < 0.05, eDifferent from 
HED, P < 0.05.Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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Psychosocial Results
Individual QOL subscales were completed at baseline and
after 10 and 14 weeks and are presented as delta values for
0 and 14 weeks, respectively. Physical functioning (W0:
6.7 ± 22; W14: 9.3 ± 19), bodily pain (W0: 6.1 ± 30; W14:
4.9 ± 25), general health (W0: 8.3 ± 14; W14: 8.4 ± 15),
vitality (W0: 11.2 ± 15; W14: 11.9 ± 14), and mental
health (W0: 6.3 ± 13; W14: 7.3 ± 14) scores significantly
increased (all P  < 0.05) in exercising individuals (all
groups except CON and ND) independent of dietary
assignment. Similarly, role emotional scores (W0: -13.2 ±
43; W14: -16.5 ± 44) were significantly (P  < 0.05)
decreased while social functioning scores were unchanged
(P > 0.05). No significant (P > 0.05) correlations were
found between the changes in the QOL subscales and
anthropometric (e.g. waist circumference) and body com-
position (e.g. body mass and DXA parameters) variables.
Body image assessment revealed significant (P  < 0.05)
percent increases from baseline in exercising individuals
irrespective of dietary assignment after 10 and 14 weeks,
respectively, for appearance evaluation (W10: 50.5 ± 20;
W14: 50.0 ± 20%), appearance orientation (W10: 6.6 ±
32; W14: 6.1 ± 32%), body area satisfaction scale (W10:
23.7 ± 19; W14: 14.7 ± 29%), and overweight preoccupa-
tion (W10: 20.1 ± 31; W14: 17.8 ± 34%) while self-classi-
fied weight (SCW) did not change. No changes (P > 0.05)
occurred for any diet or exercise group for the Rosenberg
self-esteem scale and the social physique anxiety scale.
Changes in DXA fat mass were (P < 0.05) correlated with
body area satisfaction and self-classified weight scores
while changes in percent body fat correlated (P < 0.05)
with appearance evaluation, appearance orientation,
body area satisfaction, self-classified weight and social
physique anxiety values.
Discussion
The purpose of this study was two-fold: 1) to determine
the impact of replacing dietary carbohydrate with dietary
protein and 2) to determine the impact of the Curves fit-
ness and weight loss program on weight loss, body com-
position, energy expenditure, psychosocial outcomes, and
markers of health in sedentary, obese females. This study
represents the first of a series of studies by our research
group to examine the effectiveness of the Curves fitness
and weight loss program which is currently being fol-
lowed by millions of women worldwide. Although our
study contains many strengths such as our overall sample
size, supervised exercise, dietary control measures and
inclusion of exercise-only and no exercise/no diet con-
trols, the marked difference in sample size among groups
presents some challenges with interpreting our findings.
While the authors acknowledge increasing the sample size
in these groups would have been helpful, the primary
objective was to assess the impact of altering the macronu-
trient ratio of the dietary regimens while also examining
the overall impact of the exercise and diet programs used
by the Curves system. Furthermore, statistical power anal-
ysis of our primary (e.g. waist circumference) and second-
ary outcomes (e.g. body mass and DXA body composition
variables) ranged from 0.821 – 0.998 with partial eta
squared values of 0.062 – 0.115 suggesting that our statis-
tical analysis were adequately powered for our a priori
determined end points. Our initial hypothesis was that
participation in the exercise program would promote
weight loss, improve body composition and fitness along
with reducing markers of cardiovascular disease and that
following a diet which restricted caloric intake while
replacing dietary carbohydrate with protein at controlled
fat intake levels would result in greater weight loss and
improvements in health. Results from this study show
that the greatest changes did occur in those groups that
restricted their caloric intake in combination with the
exercise program while participation in just the exercise
program appears to have little to no effect over weight loss
and body composition changes, a finding previously
reported [8].
Results from the dietary analysis revealed significant dif-
ferences in energy intake and carbohydrate and protein
intake between dietary phases (e.g. Phase I, Phase II, etc.)
and dietary groups (e.g. VLCHP and LCMP vs. HCLP).
Overall dietary compliance during the 14 week program
was deemed successful in all diet groups with the excep-
Delta change in waist circumference (cm) at 14 weeks Figure 2
Delta change in waist circumference (cm) at 14 
weeks. Data are presented as individual changes from base-
line. Each respective individual group mean and 95% confi-
dence interval are placed immediately to the right of each 
data group. HED = high-energy, high carbohydrate diet + 
exercise (n = 11); ND = no diet + exercise (n = 17); VLCHP 
= very low carbohydrate, high protein diet + exercise (n = 
48); LCMP = Low carbohydrate, moderate protein + exer-
cise (n = 37); HCLP = High carbohydrate, low protein + 
exercise (n = 41); CON = no diet + no exercise (n = 7). aDif-
ferent than CON (p < 0.05).Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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tion of the HED group, where it appears this group strug-
gled to consume their prescribed level of calories (actual
mean intake of 1846.6 ± 366.6 kcals·d1 vs. prescribed
intake of 2,600 kcals·d-1). Caloric intake in this group,
however, was higher by an average of 193 kcals·d-1, when
compared to VLCHP, LCMP and HCLP. This allowed for
comparison to lower and caloric intakes while exercising,
which was the main premise for this higher dietary pre-
scription, albeit not to the degree we originally hoped.
This is likely due to either under-reporting or the inherent
error associated with using dietary food records as recent
studies from our laboratory have suggested that the mag-
nitude of error associated with self-reporting of food
intake is greater when higher caloric intakes are being pre-
scribed [37,38]. An additional important note is that
although women in the moderate and high protein diet
groups consumed a high percentage of calories in the
form of protein, the relative intakes of this macronutrient
ranged from 0.9 to 1.1 grams PRO·kg-1·d-1, respectively,
suggesting that overall protein intake was increased above
RDA guidelines.
Waist circumference is a key predictor of diabetes and car-
diovascular disease [39]. Findings from the present study
suggest that participation in a resistance-based circuit
exercise program can significantly reduce waist circumfer-
ence irrespective of what dietary regimen is being fol-
lowed. Further when dietary carbohydrate is replaced with
protein, greater decreases in waist circumference may
result (VLCHP:   = -6.3: [-8.7, -3.8]; LCMP:   = -6.7: [-
8.7, -4.8]; HCLP:   = -5.7: [-7.5, -3.9]), but these
between-group differences were not significant (Figure 2
and Table 2). Regarding weight loss, significant reductions
in body mass were found in all groups that followed a diet
and participated in the exercise program in amounts sim-
ilar to recently published investigations [40,41]. As
expected, the greatest reductions in body mass occurred in
those groups that restricted their calories to the greatest
extent and for the longest period of time (VLCHP, LCMP
and HCLP), but there were no differences between the
amount of lost in the HCLP when compared to VLCHP
and LCMP. These findings are consistent with other inves-
tigations that investigated the impact of macronutrient
content on weight loss in diabetic and non-diabetic pop-
ulations with no exercise intervention [14,41-43]. Further,
findings from Layman [12] suggested that a higher intake
of protein with or without exercise was responsible for
greater total weight loss [12]. In the present study, partic-
ipants following the VLCHP and LCMP programs experi-
enced greater but non-significant levels of body mass and
fat mass loss when compared to the HCLP group. Similar
reductions (all P < 0.001) occurred in fat-free mass for
VLCHP, LCMP and HCLP, while significant reductions in
percent body fat were still found in all three groups. These
findings contrast with other studies that have suggested
higher protein diets may preferentially help to preserve
lean tissue [12,15] in those individuals who have replaced
dietary carbohydrate intake with protein. Many reasons
exist as to why differences in these findings exist, most
notably subtle differences in the diet and exercise inter-
ventions. Nevertheless, present findings demonstrate the
ability to lose a large percentage of weight as fat while
maintaining a large amount of fat free mass while dieting
and exercising [7,16] and to a greater extent than other
control conditions.
Reductions in energy expenditure have been reported in
conjunction with restriction of caloric intake [42,44]. This
down-regulation has subsequently been linked to difficul-
ties with weight maintenance as well as regaining the lost
body mass over time [8]. Consistent with many prior
reports, significant reductions in REE occurred after con-
suming 1,200 kcal·d-1  for the first two weeks of the
present study, even in conjunction with exercise. Caloric
intake was increased by 400 kcals·d1 for the next 8 weeks
X X
X
Delta change in body mass (kg) at 14 weeks Figure 3
Delta change in body mass (kg) at 14 weeks. Data are 
presented as individual changes from baseline. Each respec-
tive individual group mean and 95% confidence interval are 
placed immediately to the right of each data group. HED = 
high-energy, high carbohydrate diet + exercise (n = 11); ND 
= no diet + exercise (n = 17); VLCHP = very low carbohy-
drate, high protein diet + exercise (n = 48); LCMP = Low 
carbohydrate, moderate protein + exercise (n = 37); HCLP = 
High carbohydrate, low protein + exercise (n = 41); CON = 
no diet + no exercise (n = 7). aDifferent than CON, P < 0.05. 
bDifferent than ND+E, P < 0.05. cDifferent than LCMP, P < 
0.05.Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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which increased REE back to baseline levels in all groups
except HED as this group experienced further increases in
REE (Figure 5). A slight increase in energy intake during
the following 8 weeks to 1,600 kcals·d1 (which was close
to mean daily REE) stimulated increases in REE despite
participants losing a significant amount of weight and fat
mass. In these groups, REE was further increased when
participant's began ingesting a 2,600 kcal: 55:15:30 diet
with intermittent dieting (6 days out of 31) at their previ-
ously followed energy and macronutrient levels similar to
previous energy balance approaches used in the literature
[14]. Collectively, these findings suggest that relative lev-
els of energy expenditure can be maintained while com-
pleting a weekly resistance-based circuit training program
in conjunction with modest caloric restriction (phase II)
or potentially even intermittent dieting (Phase III).
As hypothesized, all groups except CON experienced
improvements in peak oxygen uptake and maximal
strength levels (Table 3) in accordance with other studies
which have employed a regular exercise program to over-
weight/obese and/or sedentary populations [7,40]. Mini-
mal studies have incorporated a circuit-style resistance
mode of exercise to this population, thus providing evi-
dence that this type of training promotes general improve-
ments in fitness in this population. Additionally, the
serum reductions in glucose (2.6%), total cholesterol
(2.5%) and LDL cholesterol (2.8%) were significant and
similar to other studies which have employed dietary reg-
imens that replace dietary carbohydrate in favor of greater
dietary protein (Table 4) [45]. While no significant group
× time effect was found for insulin (P = 0.08), individuals
in the VLCHP and LCMP groups experienced significant
reductions, providing continued support that higher
intakes of protein may help to promote such changes
[14]. A weakness of our study design is the inherent nature
of pneumatic resistance. Such exercise modes make it
impossible to determine how much resistance is actually
being applied and subsequently creates challenges for
documenting changes in total work throughout the exer-
cise program in all groups. In this regard, it is possible that
the total work completed from workout to workout and
week to week didn't change or even decreased, although
the physiological adaptations which did occur make this
unlikely. For this reason, heart rate and ratings of per-
ceived exertion were monitored throughout every exercise
session in an attempt to promote consistency from work-
out to workout, while the number of completed repeti-
tions were recorded to promote adequate progression. It
was suggested that as fitness parameters increased each
individual's ability to complete work would also be sub-
sequently increased. Although each workout was intermit-
tent in nature, heart rate monitoring did successfully keep
individual workouts in the same relative range of exercise
intensity
The relationship of leptin to weight loss, energy expendi-
ture and insulin sensitivity has been characterized
[3,46,47]. In this regard, circulating levels of leptin have
been shown to decrease in response to decreases in energy
availability [46], however, the influence of exercise and
alterations in the macronutrient ratio is still undeter-
mined. Volek and colleagues [3] suggested that significant
decreases in leptin occur as part of an 8-week weight loss
program, which similarly occurred in the present study.
Further, Sartorio et al. [46] used a combination of energy-
restricted diets with a 5 d·wk-1 aerobic and anaerobic
exercise program and reported an acute, significant reduc-
tion in leptin levels which closely mimicked changes in
body mass. As observed in the Sartorio study, serum leptin
changes in the present study mimicked body mass
changes and significantly decreased in all groups (except
CON) after 2 weeks (Table 4). No significant changes
occurred in any diet or exercise groups for markers of kid-
ney and liver function (e.g. AST, ALT, GGT, creatinine,
etc.) and fat or protein breakdown (e.g. ketones, total pro-
tein, BUN, etc.). Present findings support contentions that
Delta change in DXA fat mass (kg) at 14 weeks Figure 4
Delta change in DXA fat mass (kg) at 14 weeks. Data 
are presented as individual changes from baseline. Each 
respective individual group mean and 95% confidence interval 
are placed immediately to the right of each data group. HED 
= high-energy, high carbohydrate diet + exercise (n = 11); 
ND = no diet + exercise (n = 17); VLCHP = very low carbo-
hydrate, high protein diet + exercise (n = 48); LCMP = Low 
carbohydrate, moderate protein + exercise (n = 37); HCLP = 
High carbohydrate, low protein + exercise (n = 41); CON = 
no diet + no exercise (n = 7). aDifferent than CON, P < 0.05. 
bDifferent than ND, P < 0.05. dDifferent than VLCHP, P < 
0.05.Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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higher proteins do not invoke negative alterations in any
of these serum variables after 14 weeks in obese, but oth-
erwise health populations [1,3,43,45].
An additional area of importance relative to public health
and exercise adherence were the psychosocial assess-
ments. In this regard, individual subscales of the SF-36
(e.g. physical functioning, bodily pain, general health,
vitality, and mental health) significantly improved
throughout exercise. While it could be stated that the sig-
nificant increase in the bodily pain subscale was a nega-
tive response, it is an expected response considering the
participants were sedentary for an extended period of time
prior to the start of the study and placed in a resistance-
training program, likely invoking some stiffness and
delayed-onset muscle soreness. Additionally, significant
increases in several subscales (e.g. appearance evaluation,
appearance orientation, body area satisfaction and over-
weight preoccupation) of body image evaluation also
improved in those individuals who were following the
exercise program. In addition to improvement in several
of the psychosocial variables, changes in these variables
were significantly (P < 0.05) correlated to changes in body
composition (e.g. fat mass and body fat %). Considering
statistical probability that one of every twenty correlations
run will result in a significant finding, it is possible that
significance was found merely due to chance. While not
intended to be causal, these findings suggest that changes
in body composition may operate in conjunction with
changes in body image as a result of exercise participation.
As such our investigation has many strengths and weak-
nesses to consider when evaluating this data against other
data in this research area. Our study design could have
been more complete by including a diet only control
group with restricted caloric intake as this would have
allowed us to more closely evaluate the impact of the exer-
cise program in each dietary group. In this respect, a recent
study has illustrated a similar weight-loss effect when a
dieting only approach or a combination of exercise and
diet is used if the net shift in energy expenditure is the
same, however, a greater fitness benefit was reported
which could have implications for cardiovascular health
[40]. Additionally, while the sample size across groups
varied widely, our primary interest was in evaluating the
changes in different dietary regimens with the exercise
program. Strengths in our study involve the use of a rather
large sample over several weeks of the intervention in
comparison to other related studies. Also, a strength in the
present study is our examination of a commercial pro-
gram that is available to women all over the world and is
currently the program of choice for millions of women at
over 10,000 locations across the globe.
Conclusion
In summary, results of this study indicate that combining
a diet that restricts caloric intake in combination with a
resistance-based circuit exercise program stimulates the
greatest amount of weight loss and improvements in
measures of body composition (e.g. waist circumference,
DXA, etc.). When carbohydrate is replaced with protein
while keeping fat intake at recommended levels (VLCHP
and LCMP), larger decreases in waist circumference, body
mass, fat mass and fat-free mass when compared to a diet
that has a higher proportion of carbohydrate (HCLP) in
addition to greater decreases in fasting insulin levels. As
expected, regular participation in a resistance-based cir-
cuit exercise program resulted in marked losses of body
mass, improvements in body composition and overall
improvements in cardiovascular and musculoskeletal fit-
ness. Participation in the exercise program allowed for
weight loss without concomitant reductions in resting
energy expenditure. Additionally, those participants who
were identified to have a low resting energy expenditure at
baseline also experienced weight loss while exercising, but
being prescribed a diet higher in calories. Significant
reductions in leptin levels as well as improvements in fit-
ness, markers of health, health-related quality of life, and
body image were found for all individuals who followed
the exercise program. These findings suggest that replacing
carbohydrate with protein can be an effective strategy to
improve body composition and reduce cardiovascular
Delta change in absolute resting energy expenditure (kcald-1)  at 14 weeks Figure 5
Delta change in absolute resting energy expenditure 
(kcal·d-1) at 14 weeks. Each respective individual group 
mean and 95% confidence interval are placed immediately to 
the right of each data group. HED = high-energy, high carbo-
hydrate diet + exercise (n = 11); ND = no diet + exercise (n 
= 17); VLCHP = very low carbohydrate, high protein diet + 
exercise (n = 48); LCMP = Low carbohydrate, moderate pro-
tein + exercise (n = 37); HCLP = High carbohydrate, low 
protein + exercise (n = 41); CON = no diet + no exercise (n 
= 7). dDifferent from VLCHP, P < 0.05. eDifferent from all 
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disease markers while participating in a resistance-based
circuit exercise program in sedentary overweight women.
Abbreviations
HED: High-energy diet + exercise group; VLCHP: Very low
carbohydrate, high protein diet + exercise group; LCMP:
Low calorie, moderate protein diet + exercise group;
HCLP: High carbohydrate, low protein diet + exercise
group; CON: Control group; ND: No diet + exercise
group; U·L-1: units per liter; mmol·L-1: millimoles per
liter; μmol·L-1: micromoles per liter; pmol·L-1: picomoles
per liter; mM: millimoles; DXA: dual energy x-ray absorp-
tiometry; HOMA-IR: homeostatic model assessment of
insulin resistance.
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Table 3: Cardiorespiratory and muscular fitness changes for the high energy, high carbohydrate diet + exercise (HED; 2,600: 55:15:30), 
no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate 
protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30).
P-value
Variable Group Mean 14 Week Delta Within Group G × T
Max VO2 (ml·kg·min--1) HED 1.0 (-0.79, +2.73) 0.48 <0.05
ND 0.8 (-1.45, +3.00) 0.27
VLCHP 3.6 (+2.30, +4.94) <0.001
LCMP 1.1 (+0.13, +2.26)d <0.01
HCLP 0.9 (+0.05, +1.67)d <0.001
CON 0.1 (-2.92, +3.13) 0.52
BP 1 RM (kg·kg-1) HED 0.06 (+0.03, +0.09) <0.01 0.44
ND 0.06 (+0.04, +0.08) <0.001
VLCHP 0.04 (+0.03, +0.06) <0.001
LCMP 0.09 (+0.03, +0.16) <0.05
HCLP 0.05 (+0.03, +0.06) <0.001
CON 0.02 (-0.02, +0.05) 0.59
BP Lifting Volume (kg·kg-1) HED 1.8 (-6.07, +9.70) 0.20 0.35
ND 1.2 (-3.99, +6.37) 0.90
VLCHP 3.4 (-0.29, +7.09) 0.30
LCMP 1.0 (-3.16, +5.25) 0.18
HCLP 2.9 (+0.31, +5.58) <0.05
CON 2.7 (-2.46, +7.81) 0.59
LP 1 RM (kg·kg-1) HED 0.2 (-0.02, +0.47) 0.11 0.38
ND 0.2 (+0.09, +0.43) <0.001
VLCHP 0.3 (+0.22, +0.48) <0.001
LCMP 0.5 (+0.20, +0.73) <0.005
HCLP 0.2 (+0.13, +0.32) <0.001
CON 0.1 (-0.15, +0.37) 0.54
LP Lifting Volume (kg·kg-1) HED 2.0 (-5.76, +9.84) 0.45 0.32
ND 0.9 (-4.32, +6.08) 0.32
VLCHP 4.5 (+0.93, +8.03) <0.05
LCMP 3.9 (-0.79, +8.58) 0.24
HCLP 3.9 (+1.40, +6.48) <0.01
CON 2.3 (-2.73, +7.38) 0.28
Dietary intake is presented as energy (i.e., calories) intake: % carbohydrate: protein: fat. All data is presented as the mean plus the 95% confidence 
intervals for the delta response at week 14. Main effects for time are provided as within-group P-values. Group × time interaction effects are 
provided as GxT P-values.Significance level was set at 0.05.
dDifferent than VLCHP, P < 0.05Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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Table 4: Lipid panel, glucose, insulin, HOMA and leptin changes for the high energy, high carbohydrate diet + exercise (HED; 2,600: 
55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, 
moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30). 
P-value
Variable Group Mean 14 Week Delta Within Group G × T
Total Cholesterol (mmo·L-1) HED -0.14 (-0.49, +0.22) 0.46 0.90
ND -0.23 (-0.63, +0.17) 0.28
VLCHP -0.04 (-0.19, +0.11) 0.60
LCMP -0.13 (-0.36, +0.11) 0.31
HCLP -0.17 (-0.33, -0.01) <0.05
CON -0.15 (-0.62, +0.32) 0.55
HDL Cholesterol (mmol·L-1) HED 0.05 (-0.04, +0.14) 0.28 0.78
ND -0.05 (-0.16, +0.06) 0.40
VLCHP 0.02 (-0.03, +0.08) 0.38
LCMP 0.01 (-0.05, +0.07) 0.75
HCLP -0.01 (-0.07, +0.05) 0.67
CON 0.02 (-0.14, +0.18) 0.80
LDL Cholesterol (mmol·L-1) HED -0.28 (-0.64, +0.07) 0.15 0.54
ND -0.17 (-0.50, +0.17) 0.35
VLCHP -0.07 (-0.23, +0.09) 0.39
LCMP 0.05 (-0.21, +0.31) 0.71
HCLP -0.10 (-0.27, +0.07) 0.27
CON -0.23 (-0.60, +0.14) 0.27
Triglycerides (mmol·L-1) HED 0.18 (-0.09, +0.46)c 0.22 0.31
ND -0.04 (-0.31, +0.23) 0.79
VLCHP -0.11 (-0.32, +0.10) 0.30
LCMP -0.33 (-0.59, -0.06) <0.05
HCLP -0.13 (-0.30, +0.05) 0.18
CON 0.12 (-0.59, +0.33) 0.63
Insulin (pmol·L-1) HED 1.66 (-0.91, +4.24) 0.23 0.08
ND -0.45 (-1.24, +0.33) 0.28
VLCHP -1.23 (-2.15, -0.30) <0.05
LCMP -0.82 (-2.45, +0.82) 0.33
HCLP -0.10 (-0.61, +0.41) 0.69
CON 0.58 (-1.95, +3.12) 0.29
Glucose (mmol·L-1) HED -0.12 (-0.42, +0.18) 0.45 0.68
ND -0.15 (-0.32, +0.03) 0.12
VLCHP -0.24 (-0.43, -0.04) <0.05
LCMP -0.08 (-0.42, +0.26) 0.65
HCLP -0.22 (-0.35, -0.10) <0.001
CON -0.08 (-0.40, +0.25) 0.66
(HOMA-IR) HED 0.36 (-0.26, +0.97) 0.28 0.06
ND -0.12 (-0.31, +0.07) 0.23
VLCHP -0.35 (-0.58, -0.12) <0.01
LCMP -0.17 (-0.57, +0.23) 0.40
HCLP -0.06 (-0.19, +0.07) 0.38
CON 0.17 (-0.18, +0.52) 0.37
Leptin (pg·mL-1) HED -11.4 (-24.7, +2.0) 0.41 <0.01
ND -10.5 (-20.2, -0.9) <0.05
VLCHP -13.9 (-24.0, -3.9) 0.95
LCMP -28.5 (-40.5, -16.5) <0.001
HCLP -20.6 (-29.3, -12.0) <0.001
CON 24.9 (+1.1, +48.7) <0.001
Dietary intake is presented as energy (i.e. calories) intake: % carbohydrate: protein: fat. All data is presented as the mean plus the 95% confidence intervals for the 
delta response at week 14. Main effects for time are provided as within-group P-values. Group × time interaction effects are provided as GxT P-values. Significance 
level was set at 0.05.
cDifferent than LCMP, P < 0.05.Nutrition & Metabolism 2009, 6:23 http://www.nutritionandmetabolism.com/content/6/1/23
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